Melanoma

The article highlights 8 common sunscreen mistakes that increase the risk of deadly melanoma. It warns that enjoyable sun activities can lead to serious health consequences.

Teddi Mellencamp shared a rare update on her cancer recovery in a tearful video. She had previously announced a Stage 2 melanoma diagnosis in October 2022.

Emily Bounds, a 29-year-old former softball player from Moody, Texas, died after battling stage 4 melanoma that left her paralyzed. The community raised over $100,000 through a fundraiser to help her purchase a wheelchair-accessible van. Her coach and friends described her as a resilient leader who inspired others through her fight against the disease.

Richard Scolyer, a cancer researcher and former Australian of the year, died at 59. He was diagnosed with inoperable brain cancer in 2023 and conducted pioneering work on immunotherapy. His family shared a statement he wrote before his death.

Mary Suppe, a South Florida teacher, shares her cancer survival story ahead of Cancer Survivors Day, detailing her battle with melanoma that spread to her brain and her recovery through treatment and a positive mindset. She participated in an early immunotherapy clinical trial and now shows no signs of cancer.

A new personalized mRNA cancer therapy, intismeran autogene, combined with KEYTRUDA, reduced melanoma recurrence or death risk by 49% over five years in a phase 2b study. The treatment, developed by Merck and Moderna, showed sustained benefits and a manageable safety profile in high-risk melanoma patients. It is now in phase 3 trials.

A personalized mRNA vaccine developed by Moderna and Merck shows promise in reducing the recurrence of melanoma, the deadliest form of skin cancer, according to a five-year follow-up of a Phase 2b study.

A study found an mRNA vaccine highly effective in preventing melanoma recurrence when combined with Keytruda, an immunotherapy drug. The vaccine targets this dangerous skin cancer using personalized mRNA technology.

A study found that an mRNA vaccine is highly effective at preventing recurrence of melanoma when used in combination with Keytruda, an immunotherapy drug.

Researchers discovered that melanoma spread in mice is lowest in young mice, peaks in middle age, and declines again in very old mice. A specific immune cell type appears to regulate cancer dormancy and prevent metastasis, challenging previous assumptions about age-related cancer progression.

Melanoma skin cancer cases in the UK have reached a record high, surpassing 20,000 cases annually for the first time. This represents a significant increase in the most dangerous type of skin cancer diagnosis rates across the country.

Skin cancer cases in the UK have reached record high levels, prompting a charity to issue an urgent warning about sun safety. The increasing incidence reflects growing concerns about UV exposure and melanoma rates among the British population.

Melanoma cases in the UK have reached a record high of 20,980 diagnoses in 2022, marking the first time the number has exceeded 20,000. This represents a significant increase in the most serious form of skin cancer according to Cancer Research UK's analysis of the latest figures.

A major study warns that skin cancer cases, including deadly melanoma, are expected to surge worldwide by 2050. This increase is a global concern, with rising cases of various forms of skin cancer. The study highlights the need for awareness and preventive measures.

RFK Jr. has cleared the path for minors to use tanning beds, despite a proposed FDA rule intended to protect children from indoor tanning, which increases melanoma risk by 75%. This decision has been met with dismay from dermatologists. The removal of the proposed rule may put children at greater risk.

A shocking number of Britons deliberately sunburn themselves to achieve a tan, increasing their risk of deadly melanoma. The Bank Holiday period has prompted warnings about the health dangers of intentional sunburn.

Scientists identified HOXD13 as a key protein that drives melanoma tumor growth and immune evasion by enhancing blood supply and suppressing cancer-fighting T cells. Disabling HOXD13 reduces tumors and restores immune system activity, offering a potential new treatment approach for skin cancer.

A Swedish study demonstrates that AI can identify individuals at higher risk of melanoma using routine health data. The AI models outperformed basic methods, accurately flagging high-risk groups with some individuals having a 33% chance of developing melanoma within five years. This could lead to more targeted and effective skin cancer screening.

PerturbFate, a high-throughput single-cell platform, identifies common regulatory nodes and phenotypic states linked to vemurafenib resistance in melanoma cells. The study, published in Nature, uses CRISPR interference to map convergent regulators of drug resistance in melanoma.